Vivo Capital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001674712 · Show all filings

Period: Q1 2016 (Next →)

Filing Date: May 16, 2016

Total Value: $399M (100.0% shares, 0.0% debt)

Holdings (24)

ACRS Aclaris therapeutics 19.9%

Value $79.43M Shares 4,191,397 Est. Cost $19.11 Unrealized 0.0%

— Sagent Pharmaceuticals, Inc. 19.8%

Value $79.1M Shares 6,499,737 Est. Cost $12.17 Unrealized —

— Biotie Therapies Corp. 8.2%

Value $32.54M Shares 1,220,234 Est. Cost $26.67 Unrealized —

— Nabriva Therapeutics AG 7.1%

Value $28.24M Shares 3,151,700 Est. Cost $8.96 Unrealized —

— Eiger BioPharmaceuticals 6.7%

Value $26.82M Shares 1,599,592 Est. Cost $16.77 Unrealized —

ASND Ascendis Pharma 6.6%

Value $26.33M Shares 1,419,332 Est. Cost $18.55 Unrealized —

CDXS Codexis, Inc. 4.3%

Value $17.33M Shares 5,573,319 Est. Cost $3.85 Unrealized 0.0%

— ProNAi Therapeutics, Inc. 4.1%

Value $16.43M Shares 2,438,270 Est. Cost $6.74 Unrealized —

— Advanced Accelerator Applications S.A. 4.0%

Value $15.96M Shares 455,798 Est. Cost $35.02 Unrealized —

— Agile Therapeutics, Inc. 3.1%

Value $12.54M Shares 2,019,955 Est. Cost $6.21 Unrealized —

RGNX Regenxbio Inc. 2.7%

Value $10.7M Shares 990,449 Est. Cost $12.80 Unrealized 0.0%

— Trevena, Inc. 2.5%

Value $9.924M Shares 1,200,000 Est. Cost $8.27 Unrealized —

— Capnia, Inc. 2.2%

Value $8.885M Shares 7,466,352 Est. Cost $1.19 Unrealized —

— Kite Pharma, Inc. 2.2%

Value $8.869M Shares 193,193 Est. Cost $45.91 Unrealized —

— Akari Therapeutics Plc 1.9%

Value $7.39M Shares 527,842 Est. Cost $14.00 Unrealized —

— Dynavax Technologies Corporation 1.7%

Value $6.883M Shares 357,755 Est. Cost $19.24 Unrealized —

— MEI Pharma, Inc. 0.9%

Value $3.487M Shares 2,767,718 Est. Cost $1.26 Unrealized —

— Carbylan Therapeutics 0.7%

Value $2.691M Shares 4,204,562 Est. Cost $0.64 Unrealized —

— ChemoCentryx, Inc. 0.6%

Value $2.211M Shares 887,906 Est. Cost $2.49 Unrealized —

— ReVance Therapeutics, Inc. 0.5%

Value $1.886M Shares 77,373 Est. Cost $24.38 Unrealized —

— Ocera Therapeutics, Inc. 0.1%

Value $451K Shares 153,331 Est. Cost $2.94 Unrealized —

— Zosano Pharma Corp 0.1%

Value $227K Shares 98,515 Est. Cost $2.30 Unrealized —

— Capnia, Inc. 0.1%

Value $215K Shares 932,910 Est. Cost $0.23 Unrealized —

— Palatin Technologies, Inc. 0.0%

Value $127K Shares 234,909 Est. Cost $0.54 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	Aclaris therapeutics	4,191,397	$79.43M	19.9%	$19.11	0.0%	Common	00461U105
—	Sagent Pharmaceuticals, Inc.	6,499,737	$79.1M	19.8%	$12.17	—	Common	786692103
—	Biotie Therapies Corp.	1,220,234	$32.54M	8.2%	$26.67	—	ADR	09074D103
—	Nabriva Therapeutics AG	3,151,700	$28.24M	7.1%	$8.96	—	ADR	62957M104
—	Eiger BioPharmaceuticals	1,599,592	$26.82M	6.7%	$16.77	—	Common	28249U105
ASND	Ascendis Pharma	1,419,332	$26.33M	6.6%	$18.55	—	ADR	04351P101
CDXS	Codexis, Inc.	5,573,319	$17.33M	4.3%	$3.85	0.0%	Common	192005106
—	ProNAi Therapeutics, Inc.	2,438,270	$16.43M	4.1%	$6.74	—	Common	74346L101
—	Advanced Accelerator Applications S.A.	455,798	$15.96M	4.0%	$35.02	—	Common	00790T100
—	Agile Therapeutics, Inc.	2,019,955	$12.54M	3.1%	$6.21	—	Common	00847L100
RGNX	Regenxbio Inc.	990,449	$10.7M	2.7%	$12.80	0.0%	Common	75901B107
—	Trevena, Inc.	1,200,000	$9.924M	2.5%	$8.27	—	Common	89532E109
—	Capnia, Inc.	7,466,352	$8.885M	2.2%	$1.19	—	Common	14066L105
—	Kite Pharma, Inc.	193,193	$8.869M	2.2%	$45.91	—	Common	49803L109
—	Akari Therapeutics Plc	527,842	$7.39M	1.9%	$14.00	—	ADR	00972G108
—	Dynavax Technologies Corporation	357,755	$6.883M	1.7%	$19.24	—	Common	268158201
—	MEI Pharma, Inc.	2,767,718	$3.487M	0.9%	$1.26	—	Common	55279B202
—	Carbylan Therapeutics	4,204,562	$2.691M	0.7%	$0.64	—	Common	141384107
—	ChemoCentryx, Inc.	887,906	$2.211M	0.6%	$2.49	—	Common	16383L106
—	ReVance Therapeutics, Inc.	77,373	$1.886M	0.5%	$24.38	—	Common	761330109
—	Ocera Therapeutics, Inc.	153,331	$451K	0.1%	$2.94	—	Common	67552A108
—	Zosano Pharma Corp	98,515	$227K	0.1%	$2.30	—	Common	98979H103
—	Capnia, Inc.	932,910	$215K	0.1%	$0.23	—	Warrant	14066L113
—	Palatin Technologies, Inc.	234,909	$127K	0.0%	$0.54	—	Common	696077403